Research Article
Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value
Table 2
Comparison of clinicopathological features between MC and PDC patients for gastric cancer.
| | | MC (68 cases) | PDC (599 cases) | value | value |
| | Age | | | 4.936 | 0.026 | | ≤60 years | 34 (50.0%) | 382 (63.8%) | | | | >60 years | 34 (50.0%) | 217 (36.2%) | | | | Gender | | | 0.032 | 0.858 | | Male | 44 (64.7%) | 381 (63.6%) | | | | Female | 24 (35.3%) | 218 (36.4%) | | | | Tumor diameter | | | 2.318 | 0.128 | | ≤5 cm | 28 (41.2%) | 305 (50.9%) | | | | >5 cm | 40 (58.8%) | 294 (49.1%) | | | | Tumor location | | | 3.271 | 0.195 | | Upper 1/3 | 25 (36.8%) | 185 (30.9%) | | | | Middle 1/3 | 7 (10.3%) | 115 (19.2%) | | | | Lower 1/3 | 36 (52.9%) | 299 (49.9%) | | | | Borrmann type | | | 5.997 | 0.112 | | Borrmann I | 8 (11.8%) | 52 (8.7%) | | | | Borrmann II | 12 (17.6%) | 191 (31.9%) | | | | Borrmann III | 41 (60.3%) | 301 (50.3%) | | | | Borrmann IV | 7 (10.3%) | 55 (9.2%) | | | | Depth of invasion | | | 7.864 | 0.049 | | T1 | 2 (2.9%) | 59 (9.8%) | | | | T2 | 7 (10.3%) | 101 (16.9%) | | | | T3 | 33 (48.5%) | 280 (46.7%) | | | | T4 | 26 (38.2%) | 159 (26.5%) | | | | Lymph node metastasis | | | 5.435 | 0.143 | | N0 | 13 (19.1%) | 161 (26.9%) | | | | N1 | 15 (22.1%) | 172 (28.7%) | | | | N2 | 23 (33.8%) | 142 (23.7%) | | | | N3 | 17 (25.0%) | 124 (20.7%) | | | | TNM stage | | | 3.514 | 0.319 | | I | 6 (8.8%) | 95 (15.8%) | | | | II | 11 (16.2%) | 115 (19.2%) | | | | III | 28 (41.2%) | 228 (38.1%) | | | | IV | 23 (33.8%) | 161 (26.9%) | | | | Peritoneal dissemination | | | 5.858 | 0.016 | | P (+) | 20 (29.4%) | 104 (17.4%) | | | | P (−) | 48 (70.6%) | 495 (82.6%) | | | | Hepatic metastasis | | | 0.001 | 0.971 | | H (+) | 3 (4.4%) | 27 (4.5%) | | | | H (−) | 65 (95.6%) | 572 (95.5%) | | | | Curability | | | 1.433 | 0.231 | | Curative | 43 (63.2%) | 421 (70.3%) | | | | Noncurative | 25 (36.8%) | 178 (29.7%) | | |
|
|
